|
Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial
European Stroke Journal
💎 10 分
|
Louise Maes, Claudia Verschuere, Cathal Walsh, Christian Weimar, Francisco Purroy, Christopher Price, Catarina Fonseca, Michael D Hill, Dalius Jatuzis, Janika Kõrv, Christina Kruuse, Robert Mikulik, Paul Nederkoorn, Anna Czlonkowska, Urs Fischer, Michael McCormick, Maria Castellanos, Miguel Baptista, João Pedro Marto, Kamy Thavanesan, David J Williams, Peter Kelly, Robin Lemmens, for the CONVINCE investigators, G Vanhooren, D Hemelsoet, A Peeters, L Sinnaeve, M Hill, M Haršány, O Škoda, H Klingenberg Iversen, C Kruuse, N Solokha, J Korv, P Kraft, T Neumann-Haefelin, H Soda, K G Häusler, B Schmitz, G Thomalla, C Krogias, S Murphy, S Cronin, R Collins, D McCabe, D Williams, J Harbison, E Dolan, P Cotter, P Hickey, P Bienfait, A Członkowska, W Brola, M Baptista, J Marto, E Cuadrado, M Castellanos, D Cánovas, M Medina, J Masjuan, M Gomez-Choco, M J Serena, S Perez Sanchez, J Fernandez Dominguez, M Heldner, M Barber, N Evans, G Shim, L Sztriha, K Adie, A Ali, M Garside, L D’Anna, L Sekaran, A Bhalla, B Keegan, K Rashed, T England, G Gunathilagan, S Ivatts, P Guyler, D Lashley, A Elmerimi, M Hasan, T Hlaing, M Burn
|
2026 |
10.1093/esj/aakag033
|
付费解锁 (10分)
|